The roles and mechanism of action of the PI3K/Akt pathway in the development of neuropathic pain evoked by nerve or spinal cord injury and diabetes, and its involvement in opioid treatment effectiveness, still need to be explained since the literature clearly suggests that this pathway has therapeutic potential. The gene discussed is AKT1; the disease is diabetes mellitus.